Table 1.
Baseline sociodemographic and clinical characteristics of patients with COVID-19 presenting to a large safety-net hospital in Massachusetts between March 4, 2020 and April 30, 2020.
Table 2.
Comparison of laboratory markers between ESKD and non-ESKD patients presenting to a large safety-net hospital in Massachusetts between March 4, 2020 and April 30, 2020.
Fig 1.
Baseline and highest or lowest values for selected laboratory values in ESKD and non-ESKD groups.
Shown are means and standard deviations [for baseline White Blood Cell (WBC) count, baseline platelet count and baseline albumin], and medians and interquartile ranges [for highest WBC count, lowest platelet count, lowest albumin, lactate dehydrogenase (LDH), ferritin, C-reactive protein (CRP), and D-dimer]. Dotted line denotes the reference range.
Table 3.
Comparison of major outcomes between ESKD and non-ESKD patients.
Table 4.
Multivariable adjusted logistic regression with COVID-19 with ESKD as a predictor for clinically important outcomes.
Table 5.
Logistic regression analysis testing the association of inflammatory makers and outcomes among patients with COVID-19.
Table 6.
Characteristics and clinical presentation of ESKD patients who died compared to ESKD patients who survived with COVID-19 in a large safety-net hospital in Massachusetts between March 4, 2020 and April 30, 2020.